The Carelon Guideline Development team conducts a systematic evidence review to inform both new guidelines and annual updates. A key component of the process is an assessment of the collected evidence by a trained methodologist using standardized tools such as Quality...
Behind the scenes
CT contrast shortage
On May 9, 2022, the United States Food and Drug Administration added Omnipaque™ and Visipaque™ to their drug shortage list due to the shutdown of a GE Healthcare plant in Shanghai. Though the plant has since reopened, it is anticipated that there will be an...
myNEXUS
myNEXUS delivers integrated clinical support services for approximately 3.5 million Medicare Advantage members across 23 states through their comprehensive home benefit management program for payors. myNEXUS deploys a user-friendly platform for providers to highly...
Search function and archives added to AIM guidelines
Carelon recently launched enhancements to Carelon guidelines.* Developed based on client, reviewer and provider feedback, the guidelines now have many requested features including the following: Relevance ranked full-text search by code and/or keyword(s) Code or...
Evidence review process
Carelon clinical appropriateness guidelines are developed using a robust evidentiary review process. A team of clinicians and medical librarians conduct literature review using structured search methodologies. The collected evidence is then validated using assessment...
Oncology Pathways
The Carelon Oncology Pathways Program provides information to providers on high quality, cost-effective treatment options through the publication of optimal regimens used in the practice of medical oncology. Pathway regimens are developed by a dedicated team of...
Knowledge Services
All guideline development work performed at Carelon begins with the Knowledge Services team. This team of graduate level professionals includes a methodologist and a group of experienced medical librarians who manage the research and evidence review process. In...